| Dr David Baumgarten, MD | |
|
107 Berlin Rd, Cherry Hill, NJ 08034-3526 | |
| (856) 429-1800 | |
| (856) 429-1081 |
| Full Name | Dr David Baumgarten |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 11 Years |
| Location | 107 Berlin Rd, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770920720 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
A discovery about how the body deals with the cholesterol contained within its dying cells has suggested an exciting new approach to control people's cholesterol levels - and thus their risk of developing heart disease.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.
The ALS Association announced today that it has awarded 21 new research grants totaling nearly $3.5 million to find treatments and a cure for amyotrophic lateral sclerosis (ALS). The grants were awarded to scientists from laboratories located in nine different states in the United States as well as from the United Kingdom, France, Canada, Switzerland, Israel and Australia.
Pharmaceutical companies are finding innovative new strategies to retain market share after drug patent expiration. One of the most successful of these new strategies appears to be 'flanking.' Under this strategy, brand-name drug companies sign licensing agreements with their generic competitors to establish manufacturer- distributor relationships.
A near total ban on domestic travel could delay the spread of a flu pandemic by a week or more, particularly if the outbreak originates in a regional town or small city such as Darwin, according to new modelling by Australian researchers.
› Verified 9 days ago
| Entity Name | Pulmonary And Sleep Associates Of South Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093734022 PECOS PAC ID: 0345285797 Enrollment ID: O20050728000155 |
News Archive
A discovery about how the body deals with the cholesterol contained within its dying cells has suggested an exciting new approach to control people's cholesterol levels - and thus their risk of developing heart disease.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.
The ALS Association announced today that it has awarded 21 new research grants totaling nearly $3.5 million to find treatments and a cure for amyotrophic lateral sclerosis (ALS). The grants were awarded to scientists from laboratories located in nine different states in the United States as well as from the United Kingdom, France, Canada, Switzerland, Israel and Australia.
Pharmaceutical companies are finding innovative new strategies to retain market share after drug patent expiration. One of the most successful of these new strategies appears to be 'flanking.' Under this strategy, brand-name drug companies sign licensing agreements with their generic competitors to establish manufacturer- distributor relationships.
A near total ban on domestic travel could delay the spread of a flu pandemic by a week or more, particularly if the outbreak originates in a regional town or small city such as Darwin, according to new modelling by Australian researchers.
› Verified 9 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
A discovery about how the body deals with the cholesterol contained within its dying cells has suggested an exciting new approach to control people's cholesterol levels - and thus their risk of developing heart disease.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.
The ALS Association announced today that it has awarded 21 new research grants totaling nearly $3.5 million to find treatments and a cure for amyotrophic lateral sclerosis (ALS). The grants were awarded to scientists from laboratories located in nine different states in the United States as well as from the United Kingdom, France, Canada, Switzerland, Israel and Australia.
Pharmaceutical companies are finding innovative new strategies to retain market share after drug patent expiration. One of the most successful of these new strategies appears to be 'flanking.' Under this strategy, brand-name drug companies sign licensing agreements with their generic competitors to establish manufacturer- distributor relationships.
A near total ban on domestic travel could delay the spread of a flu pandemic by a week or more, particularly if the outbreak originates in a regional town or small city such as Darwin, according to new modelling by Australian researchers.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Baumgarten, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Dr David Baumgarten, MD 107 Berlin Rd, Cherry Hill, NJ 08034-3526 Ph: (856) 429-1800 |
News Archive
A discovery about how the body deals with the cholesterol contained within its dying cells has suggested an exciting new approach to control people's cholesterol levels - and thus their risk of developing heart disease.
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.
The ALS Association announced today that it has awarded 21 new research grants totaling nearly $3.5 million to find treatments and a cure for amyotrophic lateral sclerosis (ALS). The grants were awarded to scientists from laboratories located in nine different states in the United States as well as from the United Kingdom, France, Canada, Switzerland, Israel and Australia.
Pharmaceutical companies are finding innovative new strategies to retain market share after drug patent expiration. One of the most successful of these new strategies appears to be 'flanking.' Under this strategy, brand-name drug companies sign licensing agreements with their generic competitors to establish manufacturer- distributor relationships.
A near total ban on domestic travel could delay the spread of a flu pandemic by a week or more, particularly if the outbreak originates in a regional town or small city such as Darwin, according to new modelling by Australian researchers.
› Verified 9 days ago
Shagufta Ahsan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942 | |
Dr. Alexandr Zaslavsky, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023 | |
Dr. Tolulope Adesiyun Agunbiade, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900 | |
Garo Charles Avetian, D.O. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107 | |
Matthew Everwine, DO Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124 | |
Dr. Behjath Jafry, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823 | |
William C Groh, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300 |